Rheumatology Medical News about Ankylosing spondylitis, MHC, HLA-B27

Your Unread Messages

See All

D Scott Cunningham MD, PhD
The Best of 2009

See All Messages (1 new messages)

Hello, Melissa Velez
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The genetic background of ankylosing spondylitis
Joint, Bone, Spine, 07/27/09

Vegvan A et al. – Article summarizes the data on genetic basis of ankylosing spondylitis (AS) based on both human and rodents studies. Most relevant information on HLA as well as non-MHC alleles is also discussed.

Major histocompatibility complex (MHC), especially HLA-B27, plays a central role in susceptibility to AS
HLA-B27 confers ~20 to 50% of the total genetic risk for this disease
However, AS is definitely not a single gene disease and the genetic background of AS cannot be fully explained by associations with the MHC
Recent GWAS studies have confirmed strong association of:
- IL-1 cluster on chromosome 2
- IL-23R gene on chromosome 1, and
- ARTS1 genes on chromosome 5 with AS
Linkage analysis confirmed possible associations with other regions
The strongest linkage observed for loci on chromosome 16; moderate linkage at sites on chromosomes 3, 10, 11, 17 and 19
In the PGIS animal model, 2 susceptibility loci termed Pgis1 and Pgis2 were identified